What's Happening?
AVACEN Medical has announced the availability of narrated results from a fibromyalgia pilot study conducted in collaboration with the University of California, San Diego, and the Department of Veterans Affairs. The study, which is detailed on ClinicalTrials.gov,
demonstrated a significant reduction in pain for fibromyalgia patients using the AVACEN Treatment Method. This method involves a heat therapy system that noninvasively transfers heat into the circulatory system through the palm, leading to a reduction in widespread pain and tender points. The study's findings suggest that this method could improve the quality of life for fibromyalgia sufferers, a condition affecting millions in the U.S.
Why It's Important?
The results of the AVACEN study are significant as they offer a noninvasive, drug-free alternative for managing fibromyalgia, a condition that currently lacks effective treatment options. The AVACEN Treatment Method could potentially fill a gap in the multi-billion-dollar fibromyalgia treatment market, which is dominated by pharmaceutical products with limited efficacy and potential side effects. The study's findings could lead to broader acceptance and use of the AVACEN device, which is FDA-cleared for temporary relief of minor muscle and joint pain. This development could also influence future research and treatment approaches for chronic pain conditions.
